Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Electrophysiological characterization of scars detected by contrast enhanced magnetic resonance imaging in patients with non-ischemic cardiomyopathy.

Seizer P, Zuern CS, Maier J, Kerst G, Weig HJ, Gansser L, Kramer U, May AE, Parade U, Bigalke B, Bauer A, Gawaz M, Geisler T, Schreieck J.

Int J Cardiol. 2013 Aug 10;167(3):1070-2. doi: 10.1016/j.ijcard.2012.10.065. Epub 2012 Nov 19. No abstract available.

PMID:
23174166
2.

Assessment of left ventricular myocardial scar in infiltrative and non-ischemic cardiac diseases by free breathing three dimensional phase sensitive inversion recovery (PSIR) TurboFLASH.

Kino A, Keeling AN, Farrelly CT, Sheehan JJ, Davarpanah AH, Weele PJ, Zuehldorff S, Carr JC.

Int J Cardiovasc Imaging. 2011 Apr;27(4):527-37. doi: 10.1007/s10554-010-9640-1. Epub 2010 May 26.

PMID:
20499279
3.

Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy: implications for the ablation strategy.

Piers SR, Tao Q, van Huls van Taxis CF, Schalij MJ, van der Geest RJ, Zeppenfeld K.

Circ Arrhythm Electrophysiol. 2013 Oct;6(5):875-83. doi: 10.1161/CIRCEP.113.000537. Epub 2013 Sep 13.

4.

Impact of scar, viable myocardium, and epicardial fat on substrate identification of ventricular tachycardia in a case with nonischemic cardiomyopathy.

Sasaki T, Mudd J, Steenbergen C, Zviman MM, Miller CF, Nazarian S.

Pacing Clin Electrophysiol. 2012 Dec;35(12):e345-8. doi: 10.1111/j.1540-8159.2011.03213.x. Epub 2011 Sep 2.

5.

Prognostic value of late gadolinium enhancement in cardiomyopathy: causative risk factor or surrogate marker?

Alter P, Figiel JH.

Int J Cardiol. 2015 Feb 1;180:111-3. doi: 10.1016/j.ijcard.2014.11.173. Epub 2014 Nov 25. No abstract available.

PMID:
25438229
6.

Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance.

Lopez JE, Yeo K, Caputo G, Buonocore M, Schaefer S.

J Cardiovasc Magn Reson. 2009 Nov 11;11:46. doi: 10.1186/1532-429X-11-46.

7.

[Patterns of delayed-enhancement in MRI of ischemic and non-ischemic cardiomyopathies].

Stork A, Müllerleile K, Bansmann PM, Koops A, Meinertz T, Adam G, Lund GK.

Rofo. 2007 Jan;179(1):21-30. Review. German.

PMID:
17203440
8.

Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.

Bernhardt P, Stiller S, Kottmair E, Binner L, Spiess J, Grossmann G, Rasche V, Walcher D, Hombach V.

Int J Cardiovasc Imaging. 2011 Jul;27(6):893-900. doi: 10.1007/s10554-010-9726-9. Epub 2010 Oct 19.

PMID:
20957518
9.

Clinical application of cardiac CMR.

Al-Mallah M, Kwong RY.

Rev Cardiovasc Med. 2009 Summer;10(3):134-41. Review.

PMID:
19898290
10.

Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.

Müller KA, Müller I, Kramer U, Kandolf R, Gawaz M, Bauer A, Zuern CS.

PLoS One. 2013;8(2):e57077. doi: 10.1371/journal.pone.0057077. Epub 2013 Feb 20.

11.

New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.

Renz DM, Röttgen R, Habedank D, Wagner M, Böttcher J, Pfeil A, Dietz R, Kivelitz D, Elgeti T.

Rofo. 2011 Sep;183(9):834-41. doi: 10.1055/s-0031-1281600. Epub 2011 Aug 9.

PMID:
21830182
12.

[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].

Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.

Rev Esp Cardiol. 2007 Jan;60(1):15-23. Spanish.

13.

The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy.

Stirrat J, White JA.

Can J Cardiol. 2013 Mar;29(3):329-36. doi: 10.1016/j.cjca.2012.11.033. Review.

PMID:
23439019
14.

Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.

Rosales XQ, Moser SJ, Tran T, McCarthy B, Dunn N, Habib P, Simonetti OP, Mendell JR, Raman SV.

J Cardiovasc Magn Reson. 2011 Aug 4;13:39. doi: 10.1186/1532-429X-13-39.

15.

Cardiomyopathy: magnetic resonance imaging evaluation.

Mueller GC, Attili A.

Semin Roentgenol. 2008 Jul;43(3):204-22. doi: 10.1053/j.ro.2008.02.006. Review. No abstract available.

PMID:
18486682
16.

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.

Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ.

Eur Heart J. 2005 Aug;26(15):1461-74. Epub 2005 Apr 14. Review.

PMID:
15831557
17.

Contrast-enhanced cardiac magnetic resonance in a patient with chemotoxic cardiomyopathy.

Catalano O, Antonaci S, Moro G, Baldi M, Cobelli F, Opasich C.

J Cardiovasc Med (Hagerstown). 2007 Mar;8(3):214-5.

PMID:
17312442
18.

Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.

Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA.

Circ Cardiovasc Imaging. 2012 Jul;5(4):448-56. doi: 10.1161/CIRCIMAGING.111.971549. Epub 2012 May 9.

19.

Ablation of ventricular tachycardia in patients with nonischemic cardiomyopathy.

Bogun F, Morady F.

J Cardiovasc Electrophysiol. 2008 Nov;19(11):1227-30. doi: 10.1111/j.1540-8167.2008.01268.x.

20.

Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.

Payá E, Marín F, González J, Gimeno JR, Feliu E, Romero A, Ruiz-Espejo F, Roldán V, Climent V, de la Morena G, Valdés M.

J Card Fail. 2008 Jun;14(5):414-9. doi: 10.1016/j.cardfail.2008.02.006. Epub 2008 May 27.

PMID:
18514934

Supplemental Content

Support Center